" class="no-js "lang="en-US"> Luke Devey, BMBCh, Ph.D. - Pharmtech Focus
Tuesday, January 31, 2023
Luke Davey | Pharmtech Focus

Luke Devey, BMBCh, Ph.D.

About Luke Devey, BMBCh, Ph.D.

Chief Medical Officer, Quell Therapeutics

Related Story

Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer

November 21 2022

Quell Therapeutics Ltd, a world leader in developing engineered T-regulatory (Treg) cell therapies for serious […]